The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies.
Zheng D, Wang X, Cheng L, Qin L, Jiang Z, Zhao R, Li Y, Shi J, Wu Q, Long Y, Wang S, Tang Z, Wei W, Yang J, Li Y, Zhou H, Liu Q, Liu P, Chen X, Yao Y, Yang L, Li P.
Zheng D, et al. Among authors: li y, li p.
Front Immunol. 2022 May 26;13:808347. doi: 10.3389/fimmu.2022.808347. eCollection 2022.
Front Immunol. 2022.
PMID: 35693763
Free PMC article.